PLOD1 and neoplasm: Even at a dose of 0.02 μg, in which hEx3-LH mutants only exhibited moderate antitumor effects, the LH-HY52W tetramer inhibited tumor growth; this effect was greatly reduced at a dose of 0.002 μg (Fig. 4C).